MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with M

Misoprostol

Misoprostol 25microgram tablets

No stability information

Stability notes for Misoprostol 25microgram tablets

There are no stability notes for this medicine.

Supplier

Angusta 25microgram tablets (Norgine Pharmaceuticals Ltd)

Misoprostol 200microgram tablets

Incompatible

Stability notes for Misoprostol 200microgram tablets

Drug is moisture sensitive.

Provenance

Compatibility information is derived from Cytotec 200microgram tablets (Pfizer Ltd).

Suppliers

Cytotec 200microgram tablets (Pfizer Ltd)
Cytotec 200microgram tablets (Sigma Pharmaceuticals Plc)

Misoprostol 200microgram vaginal tablets

No stability information

Stability notes for Misoprostol 200microgram vaginal tablets

There are no stability notes for this medicine.

Supplier

Misoprostol 200microgram vaginal tablets (Sun Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.